Compare M2 Group Holdings vs Pipeline Biomedical Holdings
Customers evaluate the quality of M2 Group Holdings's products using the following success metrics.
Overview
M2 Group Holdings is based in United States
M2 Group Holdings is developing a disposable drug delivery system which will initially be used for the treatment of Type I diabetes.
Pipeline Biomedical Holdings is based in United States
Pipeline Biomedical Holdings designs or identifies and acquires unique medical products and technologies, develops them into innovative products, and brings them to market. In addition to pursuing its own concepts, Pipeline Biomedical is capable of evaluating, capitalizing, and managing businesses that possess novel intellectual property and products. Pipeline Biomedical is actively reviewing potential technologies in market segments that include medical implants, operating room equipment, surgical instruments and diagnostics. Technologies, products and ideas are developed in-house and through partnering with external sources such as universities, venture capital firms, medical institutions, companies and inventors.
Demo Video
Investors
Thomas McNerney & Partners and Novo Holdings
MAKO Surgical and The Enterprise Development Center
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because M2 Group Holdings has not claimed their profile.
Work for M2 Group Holdings? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for M2 Group Holdings?
Claim your profile now.
Information not available because Pipeline Biomedical Holdings has not claimed their profile.
Work for Pipeline Biomedical Holdings? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Pipeline Biomedical Holdings?
Claim your profile now.